COVID et... |
FAQ numéro... |
NewsLettre numéro... |
ACR |
37 |
04, |
Adulte |
|
19, |
Aérosol |
5, 11, 15, 16, 38 |
10, 18, |
AINS |
5, 35 |
|
Alcool |
|
02, |
Allaitement |
6 |
03, 06, |
Anakinra |
|
04, |
Anosmie/agueusie |
6,7,11,20 |
|
Anticoagulants |
12,14,17, |
19, |
Anisocytose |
|
21, |
Aptitude au travail |
|
04, |
Asthme/BPCO |
17 |
17, |
Autopsie |
21,31 |
|
Azithromycine |
|
08, 12, |
Baricitinib |
34 |
|
ACE2 |
|
03, |
AVC |
14,16,24,36, |
12, |
BCG |
21 |
|
BNP |
28 |
|
Cancer |
7,9, |
|
Certificats de décès |
6,9,14, |
|
Chiens et chats, Chiens renifleur |
11,16,22 |
01, 02,14, |
Chirurgie |
18 |
04, |
Climat, saison, |
|
07, |
Colchicine |
|
08, |
Collapsus, Choc cardiogénique |
7 |
02, |
Contagiosité |
1,3,4,8,14,15,19,25,26,27,36,37,39,42,43, |
03, 10,14, 17, 20, |
Cordon ombilical |
20 |
|
Coronavirus |
1,19, 27 |
|
Corticoides |
44,46, |
21, |
CPAP |
|
05, |
Crohn |
37,40, |
|
Ddimères |
3 |
|
Déconfinement |
40,43, |
|
Décubitus ventre |
|
01, |
Dengue |
39, |
|
Dépistage |
10,12, |
|
Désinfection du nez |
|
20, |
Dexaméthasone |
|
08, |
Diabete |
|
16, |
Discovery |
10,21 |
|
Distenciation physique |
|
08, |
ECG |
28 |
|
Echographie |
10,25 |
05, |
ECMO |
|
21, |
Ecole |
|
14, |
Ehpad |
|
14, |
Epidémiologie |
2,9,11,12,16,18,22,25,28,30, 34, 35, 37,40,43, |
01,03,04,06, 09,10, |
Espace QTc |
19 |
|
Ethnie |
|
19, |
Facteurs de risque |
1,2,39,45, |
04,07, |
Favipivarir |
7 |
|
Fibrinolyse |
|
02, |
Formes asymptomatiques |
3,5,9, |
08, 10, 14, |
Formes cardio |
8,9,16,28 |
13, |
Formes cliniques |
|
04, 11, |
Formes dermato |
13,17,25 31 |
|
Formes enfants |
4,6,12,18,28,32, 35 ,39,42, |
09, 12,13, |
Formes gastro |
5,9,12, |
21, |
Formes graves |
1,2,7, 17,18,20,30,34 |
|
Formes neuro |
14,22,26 |
06, |
Formes ophtalmo |
13 |
|
Formes post-covid |
41, |
15, |
Formes psychiatriques |
|
15, |
Formes sujets agés |
4,17 |
|
Génétique |
33 |
|
Grippe |
|
15, 20, |
Grossesse |
6,24,29 |
20, |
Groupes sanguins |
11 |
07, |
Guérison |
5,9, |
01, |
HIV |
30,36 |
|
HTA |
2,7, 36,39, |
|
Hydroxychloroquine |
4,9,11,13,18,21,25,26,31,34,42,43,44,45, |
01,03,05,08, 09, 11,12, 15, |
Hypokaliémie |
15 |
|
IEC/ARA2 |
5,16,20 |
|
Immunité |
11,28,30,32,38,42,45,46, |
02, 04, 09, 10, 11, 18, 19, 21, |
Immunosupression |
21,23,33 |
|
Incubation |
1,4 |
|
Interféron |
|
12, |
Intubation |
4,6,19 |
|
Ivermectine |
23 |
|
Jogging |
23 |
|
Kawasaki |
37 |
02, 09, |
Lopinavir/ritonavir |
5,7,42, |
|
Lunettes |
|
20, |
Lupus |
43, |
|
Maladie inflammatoire |
37,40, |
|
Masques |
1,3,8,18,19,20,27,29,41, |
07, 08,14, 16, 18, |
Mavrilimumab |
|
07, |
Médecine générale |
29 |
|
Mortalité |
1,3,4,8,46, |
10, 18, 20, |
Mutation |
|
16, |
Non-COVID |
16,22,41, |
|
Nutrition |
15,26 |
|
Obésité |
29,46, |
|
Orage cytokinique |
7,11,12 |
|
Origine ethnique |
|
16, |
Oxygénothérapie |
2,7,11,13,18 |
|
Pangolin |
12 |
|
PCR |
8,14,17,19,39, |
01, 17, |
Photo |
|
18, |
Pneumopathie |
3 |
|
Post covid19 |
|
13, |
Prévention |
|
04, |
Procalcitonine |
20 |
|
Profil biologique |
2,11, |
|
Profil clinique |
2 |
|
Profil radiologique |
2,3,4,7,14, |
|
Recherche clinique |
3,10,13,28 |
13, |
Rein |
26,31 |
|
Réinfection |
|
17, |
Remdesivir |
23,33, 38 |
01,03,06, 13, 16, |
Score clinique |
|
07, |
SDF |
32, 38 |
|
SDRA |
30 |
03, |
Sérologie |
9,41, |
01, |
Sérothérapie |
11,14,40, |
05, 16, |
Sexe |
43, |
17, |
Soignants |
3,6,10,15,25,30,40, |
|
Tabac |
20,29,32 |
|
Tenues de protection |
19 |
|
Tests salivaires |
|
16, 17, |
Thrombose |
14, 17, 21, 24, 35, |
03,05, 15, |
Tocilizumab |
35,44, |
11, |
Traitement |
22, 27, 34, 42, 44, |
02, 06, 08, |
Transmission materno-foetale |
01, 10, 24, |
|
Troponine |
09, 22, 28, |
08, 13, |
Vaccin |
03, 15, 27, 33, |
02, 11, 12, 15, |
Ventilation mécanique |
07, 10, 13, 30, |
|
Ver marin |
17,20, |
|
Vitamine D |
|
19, |